Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.80 |
| ▸ | MAPT | P10636 | 1/20 | 0.80 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.71 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.71 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.71 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.71 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.71 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.71 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.71 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.71 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5274631 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL6671158 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL3177336 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL11245886 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL5271383 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL19043114 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL9571961 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL9809414 | 1.00 | L3MBTL1 (0.80) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL6307346 | 0.98 | TDP1 (0.76) | L3MBTL1TDP1LMNAMAPTHDAC1 | |
| SCHEMBL8675031 | 0.94 | TDP1 (0.69) | L3MBTL1TDP1LMNAMAPTHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6444858-B2 | VAPOR PHASE | BAKER HUGHES INCORPORATED | 2002-09-03 | — | — | US | disclosed |
| US-20020019572-A1 | METHOD OF ETHOXYLATION USING VAPOR PHASE DISCHARGE OF ETHYLENE OXIDE | BAKER HUGHES INCORPORATED | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019572-A1 | METHOD OF ETHOXYLATION USING VAPOR PHASE DISCHARGE OF ETHYLENE OXIDE | ESD, LIPG, FLOT1 | L3MBTL1 4275/4885TDP1 2159/4885LMNA 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.